These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9433865

  • 1. The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs.
    Maetzel A, Ferraz MB, Bombardier C.
    Arthritis Rheum; 1998 Jan; 41(1):16-25. PubMed ID: 9433865
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.
    Simon LS, Hatoum HT, Bittman RM, Archambault WT, Polisson RP.
    Fam Med; 1996 Mar; 28(3):204-10. PubMed ID: 8900554
    [Abstract] [Full Text] [Related]

  • 3. Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.
    Kristiansen IS, Kvien TK, Nord E.
    Arthritis Rheum; 1999 Nov; 42(11):2293-302. PubMed ID: 10555023
    [Abstract] [Full Text] [Related]

  • 4. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population.
    Rahme E, Joseph L, Kong SX, Watson DJ, LeLorier J.
    Arthritis Rheum; 2000 Apr; 43(4):917-24. PubMed ID: 10765939
    [Abstract] [Full Text] [Related]

  • 5. A pharmacoeconomic comparison of misoprostol/diclofenac with diclofenac.
    Morant SV, Shield MJ, Davey PG, MacDonald TM.
    Pharmacoepidemiol Drug Saf; 2002 Apr; 11(5):393-400. PubMed ID: 12271881
    [Abstract] [Full Text] [Related]

  • 6. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A, Krahn M, Naglie G.
    Arthritis Rheum; 2003 Jun 15; 49(3):283-92. PubMed ID: 12794781
    [Abstract] [Full Text] [Related]

  • 7. [Is misoprostol effective in NSAID-induced gastrointestinal complications?].
    Stucki G, Sangha O, Michel BA.
    Schweiz Med Wochenschr; 1996 Sep 14; 126(37):1573-8. PubMed ID: 8927962
    [Abstract] [Full Text] [Related]

  • 8. [Economic evaluation of the use of diclofenac/misoprostol in the treatment of osteoarticular diseases].
    Soto Alvarez J.
    An Med Interna; 2000 Sep 14; 17(9):477-84. PubMed ID: 11100534
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
    Agrawal NM, Aziz K.
    J Rheumatol Suppl; 1998 May 14; 51():17-20. PubMed ID: 9596550
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
    Cibere J, Sibley JT, Haga M.
    J Rheumatol; 2002 Feb 14; 29(2):339-46. PubMed ID: 11838854
    [Abstract] [Full Text] [Related]

  • 15. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK, Graham DY.
    Aliment Pharmacol Ther; 2004 May 15; 19(10):1051-61. PubMed ID: 15142194
    [Abstract] [Full Text] [Related]

  • 16. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
    Jacobsen RB, Phillips BB.
    Ann Pharmacother; 2004 Sep 15; 38(9):1469-81. PubMed ID: 15213313
    [Abstract] [Full Text] [Related]

  • 17. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 15; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 18. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
    Bakowsky VS, Hanly JG.
    J Rheumatol; 1999 Jul 15; 26(7):1557-63. PubMed ID: 10405945
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of misoprostol in the prophylaxis of gastroduodenal lesions induced by short-term nonsteroidal antiinflammatory drug therapy in elderly patients. A multicenter double-blind, placebo-controlled trial.
    Piette F, Teillet L, Naudin R, Boichut D, Capron MH.
    Rev Rhum Engl Ed; 1997 Apr 15; 64(4):259-66. PubMed ID: 9178399
    [Abstract] [Full Text] [Related]

  • 20. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol.
    Goldstein JL, Larson LR, Yamashita BD.
    Am J Manag Care; 1998 May 15; 4(5):687-97. PubMed ID: 10179922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.